Delivery Order SPE2DB25D3017-SPE2DB25FVKKM
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $11,743.92, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $24,412.21. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was not subject to any set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $3,289.88 under firm fixed pricing. This contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is non-set-aside and was competitively awarded, with the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $15,925.23 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The award was not...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $61,893.35. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on a non-set-aside,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a firm fixed price of $3,302.17 and an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a small-value transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio supporting federal medical procurement. The contract is a child order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 19, 2025, for supply of Jardiance 10 mg tablets in quantities of 90 units, with a ceiling value of $62,283.78 and firm fixed pricing. This non-set-aside, competitively awarded contract is scheduled for completion by August 20, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under the company's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKKMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $53,873.78. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is scheduled for ultimate completion by August 28, 2025. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the Defense Medical Supply Chain, supplying a comprehensive range of medications and medical commodities to support military healthcare programs globally. This delivery order for Jardiance, a diabetes medication, reflects the company's role in fulfilling federal pharmaceutical procurement needs for the Defense Health Agency and other government healthcare systems. As a major for-profit pharmaceutical distributor and veteran federal contractor, AmerisourceBergen demonstrates consistent capability to meet competitive federal procurement requirements across multiple therapeutic domains through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.9k | 8/27/25 |